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Abstract
Background: Leiomyosarcoma of the inferior vena cava is a rare tumor that presents in an
insidious manner with non-specific symptoms. Given its rarity, there are no consensus guidelines
to its management. The aim of this study was to report the clinical experience in the management
of patients presenting to our institution during a 12 year period.
Patients and Methods: Four patients with leiomyosarcomas of the inferior vena cava were
managed at our institution during the period reviewed. Patient details were identified through a
search of the pathology department computerized database, and case notes were retrospectively
reviewed to obtain details of presentation and management.
Results: There were 3 females and 1 male with a mean age of 59 years. All tumors were identified
within 2 months of first symptoms. Three of the 4 had localized tumors whilst 1 patient had lung
metastases at presentation. The three patients with resectable tumors underwent radical surgical
excision of the tumor, and two patients had postoperative radiotherapy. One patient died of
recurrence at 7 months, and another at 30 months. The third patient is currently well and disease
free at 16 months. The fourth patient with metastatic disease was treated with chemotherapy alone
and survived 36 months.
Conclusion: Leiomyosarcoma of the inferior vena cava is an uncommon tumor that presents with
non-specific symptoms. At the time of presentation, tumors are usually large and resection is
challenging but probably offers the best opportunity for long-term survival.
Background
Leiomyosarcomas of the inferior vena cava (IVC) are rare
as illustrated by the fact that an International IVC Leiomy-
osarcoma registry established in 1992 collected, by means
of literature review and personal communication, only
218 cases by the time of publication of its first report in
1996 [1]. Given their anatomical location, it is not surpris-
ing that they often present insidiously with non-specific
symptoms such as: abdominal pain, weight loss, mass,
fever, weakness, anorexia, vomiting, night sweats, dysp-
Published: 04 January 2006
World Journal of Surgical Oncology 2006, 4:1 doi:10.1186/1477-7819-4-1
Received: 28 September 2005
Accepted: 04 January 2006
This article is available from: http://www.wjso.com/content/4/1/1
© 2006 Abisi et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.World Journal of Surgical Oncology 2006, 4:1 http://www.wjso.com/content/4/1/1
Page 2 of 6
(page number not for citation purposes)
noea, or they may present with Budd-Chiari syndrome
[2,3].
IVC Leiomyosarcomas are classified anatomically accord-
ing to their relationship to the liver and renal vessels:
lower or Segment I (below the renal vessels); middle or
Segment II (renal vessels to retrohepatic IVC) and upper
or Segment III (suprahepatic IVC) [4]. The management
of these tumors has been, where possible, by means of
radical  en-bloc  resection with a view of achieving clear
margins. However, in spite of an overall 50% 5-year sur-
vival, half of the tumors recur either locally or metastasize
[1,3].
We present our experience with four cases of IVC leiomy-
osarcoma managed at our institution between January
1993 and December 2004.
Table 1: Demographic features and presenting symptoms of patients with IVC leiomyosarcoma.
Patients
1234
Demographics
Sex Female Female Male Female
A g e 5 76 05 76 1
Symptoms & Signs
Abdominal Pain Yes Yes No Yes
Weakness No Yes Yes Yes
Anorexia No Yes No Yes
Vomiting No No No Yes
Night sweats No No No No
Dyspnoea No No No No
Mass No No No No
F e v e r N oN oN oN o
Abdominal wall veins
distension
Y e sN oN oN o
Diagnosis
Modalities used USS + CT USS + CT CT USS + CT
Location Lower Middle Upper Middle
Size 8 × 14 cm 8 × 7 cm 10 × 10.5 cm 9.5 × 7 cm
Embolus present No No Yes No
Metastasis present Yes (Lung) No No No
Biopsy performed Yes No No No
USS – ultrasound scan; CT – computed tomography
Table 2: Management and outcome data for patients with IVC leiomyosarcoma.
Patients
1234
Management
Operation No Resection and IVC PTFE 
Patch
Resection and primary 
repair
Resection and IVC Vein 
Patch
C h e m o t h e r a p y Y e sN oN oN o
Adjuvant therapy None Radiotherapy None Radiotherapy
Histological grade High High High High
Complications
Limb oedema NA No No No
Venous insufficiency NA No No No
Other None No CVA No
Follow-up
Recurrence - No Yes (5 months) No
Status Dead Dead Dead Alive
Survival 36 months 30 months 7 months 16 months
NA – not applicable; CVA – cerebrovascular accidentWorld Journal of Surgical Oncology 2006, 4:1 http://www.wjso.com/content/4/1/1
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Patients and methods
From January 1993 to December 2004, 4 patients were
diagnosed with leiomyosarcomas of the IVC. There were 3
females and 1 male with a mean age of 59 years (range:
57–61 years). The demographic details and symptoms at
presentation are summarized in Table 1.
Clinical data was obtained from review of the patient
notes, whilst radiological and histological results were
obtained from prospectively maintained departmental
computerized databases.
Results
All 4 patients were symptomatic at presentation although
there was significant variation in symptoms between
patients (Table 1). Patient 1 was referred specifically for
investigation of distended abdominal wall veins.
The diagnosis of a caval tumor was made on an ultra-
sound scan (USS) in 3 of the 4 cases and on computed
tomography (CT) in the fourth. CT scans were performed
to further characterize the origin of the tumors, demon-
strate any contiguous invasion, and to exclude extra-
abdominal metastases (Figure 1). Patient 3 was diagnosed
with a tumor embolus to the right atrium preoperatively.
No further preoperative imaging was performed. Given
the location of the tumors, and based on experience with
other sarcomas, no biopsy was performed preoperatively
for the 3 patients undergoing surgical excision. Patient 1
underwent biopsy of the primary tumor confirm the diag-
nosis prior to commencement of chemotherapy.
Computerized tomographic scan of patient 1 demonstrating a large tumor Figure 1
Computerized tomographic scan of patient 1 demonstrating a large tumor.World Journal of Surgical Oncology 2006, 4:1 http://www.wjso.com/content/4/1/1
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Of the patients who underwent laparotomy, the tumor
was excised en-bloc in all 3 cases. Patient 3 also underwent
a thoracotomy and excision of a tumor embolus from the
right atrium. In this patient, the point of origin of the
tumor on the IVC was narrow and there was enough
mobility to primarily close the IVC. Whilst in the remain-
ing 2 cases, the tumor had a broad base. In these cases, the
tumor was excised with a generous cuff of normal IVC
wall, the defect was patched with a portion of long saphe-
nous vein in patient 4 (Duplex ultrasound was used pre-
operatively to demonstrate the absence of deep venous
thromboses, and deep venous incompetence in the lower
limbs. In-patient 2 a PTFE patch was used to repair the IVC
defect.
All tumors were large volume masses and had the classical
tan-colored, nodular appearance (Figure 2). Histological
examination revealed all to be high-grade leiomyosarco-
mas composed of spindle cells with positive immunohis-
tochemistry staining for Desmin, HHF 35(muscle specific
actin), SMA (smooth muscles actin), and negative for epi-
thelial marker AE1/AE3, S100 protein confirming smooth
muscles origin, and excluding nerve sheath origin (Figure
3).
The postoperative course was unremarkable for 2 patients.
Patient 3, however, suffered a cerebrovascular accident
perioperatively, but subsequently made a full recovery.
Importantly, there were no complications in relation to
the venous blood flow in the inferior vena cava and no
renal impairment. Two of the patients (patient 2 and 4)
undergoing resection received postoperative radiother-
apy.
Patient 1 had a variety of chemotherapy protocols as well
as palliative therapy, and survived 36 months. Disease
recurrence occurred in patients 2 and 3. Patient 3 pre-
sented with widespread metastases and died at 7 months,
whilst patient 2 developed disseminated disease 2 years
after his surgery and died at 30 months post resection.
Patient 4 is alive and disease free at 16 months post sur-
gery.
Gross appearance of the tumor Figure 2
Gross appearance of the tumor.World Journal of Surgical Oncology 2006, 4:1 http://www.wjso.com/content/4/1/1
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Discussion
The first reported case of leiomyosarcoma of the inferior
vena cava was documented in the German literature by
Perl [5] in 1871 but as of 1996 only 218 had been col-
lected [1]. Although only 2% of leiomyosarcomas are vas-
cular in origin, tumors of the IVC account for at least half
the cases [4]. The majority of cases (75–90%) occur in
women [4].
Leiomyosarcomas of the IVC are rare malignant tumors
originating from the smooth muscle cells of the media of
the cava and demonstrate three growth patterns – extralu-
minal, intraluminal or both [6]. The tumors are encapsu-
lated, consisting of lobulated whorls, and histological
examination demonstrates typical spindle-shaped bun-
dles of cells with high mitotic activity and positive stain-
ing for desmin, HHF35, vimentin and smooth muscle
actin.
This tumor commonly presents with a few months history
of vague upper abdominal symptoms including pain,
anorexia and vomiting; but may also present with more
distinct signs such as an abdominal mass, deep venous
thrombosis due to IVC occlusion, or less commonly as an
acute Budd-Chiari Syndrome. However metastasis may be
the first presentation of the tumor such as in case 1.
Given the rarity of the tumor, and in the absence of symp-
toms and signs of IVC compression, the identification of
an IVC leiomyosarcoma is often an unexpected finding on
imaging with USS or CT. In 3 of the 4 cases in this series,
the tumor was identified on USS and a CT scan was per-
formed to determine the origin, evaluate any local inva-
sion of the tumor and exclude pulmonary metastases. In
all 3 cases undergoing surgery, a diagnosis of leiomyosar-
coma was suspected preoperatively. Other imaging
modalities that aid the diagnosis of IVC sarcomas include
vena cavography, which allows biopsy of the tumor. Nev-
ertheless, in some cases, the precise origin of the tumor
cannot be confirmed preoperatively. Furthermore, percu-
taneous biopsy to confirm histology of tumors in this
region is often not possible due to the anatomical location
of the IVC. Thus the surgeon is often faced with a tumor
of uncertain type and origin at laparotomy.
Whilst there is no strong evidence base for the manage-
ment of IVC leiomyosarcomas, the treatment of choice
based on the available literature is radical en-bloc surgical
Photomicrograph of the edge of the tumour (× 40) Figure 3
Photomicrograph of the edge of the tumour (× 40). (A). The tumour is composed of spindle cells which show nuclear 
pleomorphism with occasional giant nuclei (Hematoxylin and eosin × 200), (B). Immunohistochemistry for epithelial marker 
AE1/AE3 (C), and for S100 (D) is negative, but tumor is strongly positive for smooth muscle marker smooth muscle actin(E).Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
World Journal of Surgical Oncology 2006, 4:1 http://www.wjso.com/content/4/1/1
Page 6 of 6
(page number not for citation purposes)
excision with a view to obtaining negative resection mar-
gins. A number of techniques have been reported for deal-
ing with the IVC following excision including IVC
ligation; primary repair of IVC; patching of IVC and inter-
position grafting with a synthetic conduit. In the largest
single institute series of 25 patients over a 20 year period,
Hollenbeck et al [7], concluded that primary repair was
the method of choice where applicable as this was associ-
ated with the lowest complication rate. In our limited
experience, patching of the IVC with a segment of long
saphenous vein allowed adequate tumor resection with-
out constricting the IVC. In the single case in which a pri-
mary repair was performed, tumor recurred although it is
uncertain as to whether a wider resection and caval recon-
stitution would have changed the outcome.
When radical surgery is performed, 5- and 10-year results
of 49.4% and 29.5% respectively have been reported [1].
However, recurrence rates are as high as 50% and thus sur-
gery may simply be providing palliation in many cases
[3]. Tumors of the retrohepatic IVC tend to present earlier
as a result of pressure exerted on surrounding structures
and as such have a superior prognosis with 5- and 10-year
survival rates of 56.7% and 47.3% [1]. Other favorable
factors identified by the registry include abdominal pain,
the presence of a mass and the ability to achieve clear
resection margins whereas poor prognostic indicators
include high-grade tumors, suprahepatic tumors, and
presentation with IVC occlusion or Budd-Chiari syn-
drome.
The role of chemotherapy and radiotherapy in the treat-
ment of IVC leiomyosarcoma, either as a primary modal-
ity or as an adjuvant, remains to be proven. In this series,
different chemotherapy protocols provided good pallia-
tion for a patient presenting with advanced disease. In the
remaining three patients, only two underwent radiother-
apy with a view to obtaining local control and prevention
of local recurrence.
Conclusion
Whilst IVC leiomyosarcomas are certainly rare, long-term
survival depends on obtaining an early diagnosis and per-
forming extensive surgery. The more frequent use of CT in
the investigation of patients with abdominal symptoms
may aid the earlier diagnosis of these tumors.
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